Edythe Danick London

Title(s)Professor-in-Residence, Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor-in-Residence, Molecular and Medical Pharmacology


    Collapse Biography 
    Collapse Education and Training
    University of Maryland: , Baltimore, MDPhD1976Pharmacology
    Johns Hopkins School of Medicine, Baltimore, MDpostdoc1979Neuropsychopharmacology
    Collapse Awards and Honors
    American Association for the Advancement of Science2011Scientific Freedom & Responsibility Award
    University of California Los Angeles2016Postdoctoral Mentoring Award
    University of California Los Angeles2019H.W. Magoun Lectureship
    McLean Hospital2020Women in Science Lectureship
    College on Problems of Drug Dependence2023Nathan B. Eddy Lifetime Achievement Award

    Collapse Overview 
    Collapse Overview
    Edythe D. London, Ph.D., holds the Thomas P. and Katherine K. Pike Chair in Addictive Studies.

    Collapse Research 
    Collapse Research Activities and Funding
    Mapping brain glutamate in humans: sex differences in cigarette smokers
    NIH R03DA052719Apr 1, 2021 - Mar 31, 2023
    Role: Principal Investigator
    Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder
    NIH UG3DA048388May 15, 2019 - Nov 30, 2022
    Role: Principal Investigator
    Exercise in Methamphetamine Use Disorder: Dopamine Receptor Upregulation and Neural Function
    NIH R01DA045162Jul 1, 2018 - Apr 30, 2023
    Role: Principal Investigator
    Neural Substrates of Cigarette Craving, Withdrawal, and Relief: Male-Female Differences
    NIH R37DA044467Sep 1, 2017 - Aug 31, 2023
    Role: Principal Investigator
    Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
    NIH R21DA042347Jun 1, 2017 - May 31, 2021
    Role: Principal Investigator
    Effects of Oral Contraceptives on Emotion Regulation
    NIH R21DA040168Aug 15, 2016 - Jul 31, 2018
    Role: Principal Investigator
    Attentional Bias Modification in Methamphetamine Use Disorder
    NIH R21DA040156Jul 1, 2015 - Jun 30, 2017
    Role: Principal Investigator
    Behavioral and Neural Response to Reduced Nicotine Cigarettes in Young Smokers
    NIH R01DA036487Sep 30, 2013 - Aug 31, 2016
    Role: Principal Investigator
    Neural Substrates of Emotion Regulation in Premenstrual Dysphoric Disorder
    NIH R21MH098668May 1, 2013 - Apr 30, 2016
    Role: Principal Investigator
    UCLA Training Program in the Translational Neuroscience of Drug Abuse (TNDA)
    NIH T32DA024635Jul 1, 2008 - Jun 30, 2023
    Role: Principal Investigator
    Response Inhibition and Dopamine Neurotransmission (RI) (4 of 8)
    NIH RL1DA024853Sep 30, 2007 - Oct 31, 2013
    Role: Principal Investigator
    Methamphetamine Abuse, Inhibitory Control: Implications for Treatment
    NIH P20DA022539Sep 30, 2006 - Apr 30, 2011
    Role: Principal Investigator
    Neural Systems, Inhibitory Control, and Methamphetamine Dependence
    NIH R01DA020726Sep 30, 2005 - Aug 31, 2010
    Role: Principal Investigator
    Early Methamphetamine Abstinence: fMRI and Cognition
    NIH R01DA015179Sep 1, 2003 - Jun 30, 2007
    Role: Principal Investigator
    Nicotine Withdrawal, Smoking &Cognition: an fMRI Study
    NIH R01DA014093Sep 30, 2001 - Apr 30, 2006
    Role: Principal Investigator
    Human Brain Function And Drug Abuse
    NIH Z01DA000385
    Role: Co-Principal Investigator
    NEUROCHEMICAL INTERACTIONS AND BEHAVIOR SEQUELLA IN MODELS OF DRUG ABUSE
    NIH Z01DA000386
    Role: Principal Investigator
    FUNCTIONAL CHARACTERIZATION OF ANATOMICAL SITES ASSOCIATED WITH WITHDRAWAL
    NIH Z01DA000395
    Role: Co-Principal Investigator
    Biochemistry Of Ligand Gated Ion Channels Important To D
    NIH Z01DA000403
    Role: Co-Principal Investigator
    Development Of New Approaches To Neuroimaging with PET and SPECT
    NIH Z01DA000405
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review. JAMA Psychiatry. 2024 Apr 01; 81(4):414-425. Addiction Cue-Reactivity Initiative (ACRI) Network, Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork JM, Claus ED, Prisciandaro JJ, Wilson SJ, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady KT, Brewer JA, Childress AR, Courtney KE, Ebrahimi M, Filbey FM, Garavan H, Ghahremani DG, Goldstein RZ, Goudriaan AE, Grodin EN, Hanlon CA, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst RJ, Joseph JE, Juliano AC, Kaufman MJ, Kiefer F, Khojasteh Zonoozi A, Kuplicki RT, Leyton M, London ED, Mackey S, McClernon FJ, Mellick WH, Morley K, Noori HR, Oghabian MA, Oliver JA, Owens M, Paulus MP, Perini I, Rafei P, Ray LA, Sinha R, Smolka MN, Soleimani G, Spanagel R, Steele VR, Tapert SF, Vollstädt-Klein S, Wetherill RR, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza MN, Janes AC, Kober H, Zilverstand A, Ekhtiari H. PMID: 38324323.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Structural indices of brain aging in methamphetamine use disorder. Drug Alcohol Depend. 2024 Mar 01; 256:111107. Petzold J, Pochon JF, Ghahremani DG, London ED. PMID: 38330525.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Recalibrating single-study effect sizes using hierarchical Bayesian models. Front Neuroimaging. 2023; 2:1138193. Cao Z, McCabe M, Callas P, Cupertino RB, Ottino-González J, Murphy A, Pancholi D, Schwab N, Catherine O, Hutchison K, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Li CR, Thompson WK, Morales AM, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Momenan R, Paulus MP, Schmaal L, Sinha R, Solowij N, Stein DJ, Stein EA, Uhlmann A, van Holst RJ, Veltman DJ, Wiers RW, Yücel M, Zhang S, Conrod P, Mackey S, Garavan H, ENIGMA Addiction Working Group. PMID: 38179200; PMCID: PMC10764546.
      View in: PubMed   Mentions:
    4. Value-based decision-making predicts alcohol use and related problems in young men. J Psychopharmacol. 2023 Dec; 37(12):1218-1226. Petzold J, Hentschel A, Chen H, Kuitunen-Paul S, London ED, Heinz A, Smolka MN. PMID: 37994802; PMCID: PMC10714696.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Mindfulness and clinical correlates in methamphetamine use disorder. Drug Alcohol Depend. 2023 Dec 01; 253:111029. Jarrett O, London ED, Mahmoudie T, Suh J, Ghahremani D, Dean AC. PMID: 38006669.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Smoking, tobacco dependence, and neurometabolites in the dorsal anterior cingulate cortex. Mol Psychiatry. 2023 Nov; 28(11):4756-4765. O'Neill J, Diaz MP, Alger JR, Pochon JB, Ghahremani D, Dean AC, Tyndale RF, Petersen N, Marohnic S, Karaiskaki A, London ED. PMID: 37749232; PMCID: PMC10914613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity. Drug Alcohol Depend. 2023 Aug 01; 249:109919. Tabibnia G, Ghahremani DG, Pochon JF, Diaz MP, London ED. PMID: 37270935; PMCID: PMC10516582.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Decomposing risky decision-making in methamphetamine use disorder: Behavioral updating and D2 dopamine receptors. Drug Alcohol Depend. 2023 05 01; 246:109860. Guttman Z, Mandelkern M, Ghahremani DG, Kohno M, Dean AC, London ED. PMID: 37004462; PMCID: PMC10814877.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Nicotine dependence and insula subregions: functional connectivity and cue-induced activation. Neuropsychopharmacology. 2023 05; 48(6):936-945. Ghahremani DG, Pochon JF, Diaz MP, Tyndale RF, Dean AC, London ED. PMID: 36869233; PMCID: PMC10156746.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Reduced neural functional connectivity during working memory performance in methamphetamine use disorder. Drug Alcohol Depend. 2023 02 01; 243:109764. Nestor LJ, Ghahremani DG, London ED. PMID: 36610253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Denial and Diagnosis of Methamphetamine Dependence Severity. Subst Abuse. 2022; 16:11782218221135721. Rice M, Dean AC, Suh J, London ED. PMID: 36385745; PMCID: PMC9647299.
      View in: PubMed   Mentions:
    12. The Effects of Citalopram and Thalamic Dopamine D2/3 Receptor Availability on Decision-Making and Loss Aversion in Alcohol Dependence. Psychiatry J. 2022; 2022:5663274. Zorick T, Okita K, Renard KB, Mandelkern MA, Brody AL, London ED. PMID: 36249526; PMCID: PMC9553840.
      View in: PubMed   Mentions: 5  
    13. Cortical thickness and related depressive symptoms in early abstinence from chronic methamphetamine use. Addict Biol. 2022 09; 27(5):e13205. Petzold J, Dean AC, Pochon JB, Ghahremani DG, De La Garza R, London ED. PMID: 36001419; PMCID: PMC9413352.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addict Biol. 2022 07; 27(4):e13182. Grodin EN, Nieto SJ, Meredith LR, Burnette E, O'Neill J, Alger J, London ED, Miotto K, Evans CJ, Irwin MR, Ray LA. PMID: 35754106; PMCID: PMC9888600.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    15. Brain structural covariance network differences in adults with alcohol dependence and heavy-drinking adolescents. Addiction. 2022 05; 117(5):1312-1325. Ottino-González J, Garavan H, ENIGMA-Addiction and IMAGEN consortiums. PMID: 34907616.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nat Protoc. 2022 03; 17(3):567-595. Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA, Prisciandaro JJ, Wüstenberg T, Anton RF, Bach P, Baldacchino A, Beck A, Bjork JM, Brewer J, Childress AR, Claus ED, Courtney KE, Ebrahimi M, Filbey FM, Ghahremani DG, Azbari PG, Goldstein RZ, Goudriaan AE, Grodin EN, Hamilton JP, Hanlon CA, Hassani-Abharian P, Heinz A, Joseph JE, Kiefer F, Zonoozi AK, Kober H, Kuplicki R, Li Q, London ED, McClernon J, Noori HR, Owens MM, Paulus MP, Perini I, Potenza M, Potvin S, Ray L, Schacht JP, Seo D, Sinha R, Smolka MN, Spanagel R, Steele VR, Stein EA, Steins-Loeber S, Tapert SF, Verdejo-Garcia A, Vollstädt-Klein S, Wetherill RR, Wilson SJ, Witkiewitz K, Yuan K, Zhang X, Zilverstand A. PMID: 35121856; PMCID: PMC9063851.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    17. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behav Res Ther. 2022 03; 150:104032. Wolitzky-Taylor K, Glasner S, Tanner A, Ghahremani DG, London ED. PMID: 35032700.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    18. White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group. Drug Alcohol Depend. 2022 01 01; 230:109185. Ottino-González J, Uhlmann A, Hahn S, Cao Z, Cupertino RB, Schwab N, Allgaier N, Alia-Klein N, Ekhtiari H, Fouche JP, Goldstein RZ, Li CR, Lochner C, London ED, Luijten M, Masjoodi S, Momenan R, Oghabian MA, Roos A, Stein DJ, Stein EA, Veltman DJ, Verdejo-García A, Zhang S, Zhao M, Zhong N, Jahanshad N, Thompson PM, Conrod P, Mackey S, Garavan H. PMID: 34861493; PMCID: PMC8952409.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Sex Differences in the Association of Cigarette Craving With Insula Structure. Int J Neuropsychopharmacol. 2021 08 20; 24(8):624-633. Perez Diaz M, Pochon JB, Ghahremani DG, Dean AC, Faulkner P, Petersen N, Tyndale RF, Donis A, Paez D, Cahuantzi C, Hellemann GS, London ED. PMID: 33830218; PMCID: PMC8378076.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Age Influences Loss Aversion Through Effects on Posterior Cingulate Cortical Thickness. Front Neurosci. 2021; 15:673106. Guttman ZR, Ghahremani DG, Pochon JB, Dean AC, London ED. PMID: 34321994; PMCID: PMC8311492.
      View in: PubMed   Mentions: 2  
    21. Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics. Neuropsychopharmacology. 2021 09; 46(10):1788-1801. Lam M, Chen CY, Ge T, Xia Y, Hill DW, Trampush JW, Yu J, Knowles E, Davies G, Stahl EA, Huckins L, Liewald DC, Djurovic S, Melle I, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Hartmann AM, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Koltai DC, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Smyrnis N, Bilder RM, Freimer NB, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Huang H, Liu C, Malhotra AK, Lencz T. PMID: 34035472; PMCID: PMC8357785.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    22. Functional connectivity of the anterior insula during withdrawal from cigarette smoking. Neuropsychopharmacology. 2021 11; 46(12):2083-2089. Ghahremani DG, Pochon JB, Perez Diaz M, Tyndale RF, Dean AC, London ED. PMID: 34035468; PMCID: PMC8505622.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Executive Function and Contingency Management in Methamphetamine Use Disorder. J Alcohol Drug Depend. 2021; 9(5). van Nunen LJ, Lake MT, Ipser JC, Stein DJ, Shoptaw SJ, London ED. PMID: 34423073; PMCID: PMC8378238.
      View in: PubMed   Mentions: 1  
    24. Targeting mGlu5 for Methamphetamine Use Disorder. Pharmacol Ther. 2021 08; 224:107831. Petzold J, Szumlinski KK, London ED. PMID: 33705840.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    25. Mapping cortical and subcortical asymmetries in substance dependence: Findings from the ENIGMA Addiction Working Group. Addict Biol. 2021 09; 26(5):e13010. Cao Z, Ottino-Gonzalez J, Cupertino RB, Schwab N, Hoke C, Catherine O, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Li CR, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Momenan R, Paulus MP, Schmaal L, Sinha R, Sjoerds Z, Solowij N, Stein DJ, Stein EA, Uhlmann A, van Holst RJ, Veltman DJ, Wiers RW, Yücel M, Zhang S, Jahanshad N, Thompson PM, Conrod P, Mackey S, Garavan H. PMID: 33508888; PMCID: PMC8317852.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    26. Effects of oral contraceptive pills on mood and magnetic resonance imaging measures of prefrontal cortical thickness. Mol Psychiatry. 2021 03; 26(3):917-926. Petersen N, Kearley NW, Ghahremani DG, Pochon JB, Fry ME, Rapkin AJ, London ED. PMID: 33420480; PMCID: PMC7914152.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. Striatal dopamine D2-type receptor availability and peripheral 17β-estradiol. Mol Psychiatry. 2021 06; 26(6):2038-2047. Petersen N, Rapkin AJ, Okita K, Kinney KR, Mizuno T, Mandelkern MA, London ED. PMID: 33420479; PMCID: PMC9196143.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. The relationship between duration of abstinence and gray-matter brain structure in chronic methamphetamine users. Am J Drug Alcohol Abuse. 2021 01 02; 47(1):65-73. Nie L, Ghahremani DG, Mandelkern MA, Dean AC, Luo W, Ren A, Li J, London ED. PMID: 33426968.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug Alcohol Depend. 2021 01 01; 218:108391. Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, London ED. PMID: 33153830; PMCID: PMC7750289.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. Predicting alcohol dependence from multi-site brain structural measures. Hum Brain Mapp. 2022 01; 43(1):555-565. Hahn S, Mackey S, Cousijn J, Foxe JJ, Heinz A, Hester R, Hutchinson K, Kiefer F, Korucuoglu O, Lett T, Li CR, London E, Lorenzetti V, Maartje L, Momenan R, Orr C, Paulus M, Schmaal L, Sinha R, Sjoerds Z, Stein DJ, Stein E, van Holst RJ, Veltman D, Walter H, Wiers RW, Yucel M, Thompson PM, Conrod P, Allgaier N, Garavan H. PMID: 33064342; PMCID: PMC8675424.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    31. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users. Addict Biol. 2021 05; 26(3):e12950. Dean AC, Nurmi EL, Morales AM, Cho AK, Seaman LC, London ED. PMID: 32767519; PMCID: PMC7865018.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Neural Basis of Smoking-Related Difficulties in Emotion Regulation. Int J Neuropsychopharmacol. 2020 07 29; 23(7):409-416. Faulkner P, Dean AC, Ghahremani DG, London ED. PMID: 32221527; PMCID: PMC7387763.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Amygdala Structural Connectivity Is Associated With Impulsive Choice and Difficulty Quitting Smoking. Front Behav Neurosci. 2020; 14:117. Bari AA, Sparks H, Levinson S, Wilson B, London ED, Langevin JP, Pouratian N. PMID: 32714164; PMCID: PMC7351509.
      View in: PubMed   Mentions: 2  
    34. No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug Alcohol Depend. 2020 Aug 01; 213:108104. London ED, Okita K, Kinney KR, Dean AC, McClintick MN, Rizor EJ, Johnson MC, Mahmoudie T, Brody AL, Nurmi EL, Seaman LC, Farahi J, Ginder N, Mandelkern MA. PMID: 32570138; PMCID: PMC9059651.
      View in: PubMed   Mentions: 6     Fields:    
    35. The Influence of Alexithymia on Alcohol Craving, Health-Related Quality of Life and Gender in Alcohol-Dependent Outpatients. J Psychoactive Drugs. 2020 Sep-Oct; 52(4):366-376. Thorberg FA, Hasking P, Huang YL, Lyvers M, Young RM, Connor JP, London ED, Feeney GFX. PMID: 32429771.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):565-576. Lim AC, Grodin EN, Green R, Venegas A, Meredith LR, Courtney KE, Moallem NR, Sayegh P, London ED, Ray LA. PMID: 32343625; PMCID: PMC7920534.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry. Drug Alcohol Depend. 2020 04 01; 209:107930. Moeller SJ, Kundu P, Bachi K, Maloney T, Malaker P, Parvaz MA, Alia-Klein N, London ED, Goldstein RZ. PMID: 32145661; PMCID: PMC7170015.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Decision-Making by Patients With Methamphetamine Use Disorder Receiving Contingency Management Treatment: Magnitude and Frequency Effects. Front Psychiatry. 2020; 11:22. Lake MT, Shoptaw S, Ipser JC, Takada S, van Nunen LJ, Lipinska G, Stein DJ, London ED. PMID: 32180733; PMCID: PMC7058183.
      View in: PubMed   Mentions: 6  
    39. Human Brain Imaging Links Dopaminergic Systems to Impulsivity. Curr Top Behav Neurosci. 2020; 47:53-71. London ED. PMID: 31907881.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Contingency management treatment for methamphetamine use disorder in South Africa. Drug Alcohol Rev. 2020 03; 39(3):216-222. Okafor CN, Stein DJ, Dannatt L, Ipser J, van Nunen LJ, Lake MT, Krishnamurti T, London ED, Shoptaw S. PMID: 31863530; PMCID: PMC7647047.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. Resting-state functional connectivity in women with PMDD. Transl Psychiatry. 2019 12 11; 9(1):339. Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Wijker N, Liang L, London ED. PMID: 31827073; PMCID: PMC6906514.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    42. Presynaptic dopamine function measured with [18F]fluorodopa and L-DOPA effects on impulsive choice. Sci Rep. 2019 11 29; 9(1):17927. Petzold J, Lee Y, Pooseh S, Oehme L, Beuthien-Baumann B, London ED, Goschke T, Smolka MN. PMID: 31784559; PMCID: PMC6884626.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    43. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addict Biol. 2020 11; 25(6):e12830. Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, Brooks S, Caparelli EC, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Jahanshad N, Kaag AM, Korucuoglu O, Li CR, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Meda SA, Momenan R, Morales A, Orr C, Paulus MP, Pearlson G, Reneman L, Schmaal L, Sinha R, Solowij N, Stein DJ, Stein EA, Tang D, Uhlmann A, van Holst R, Veltman DJ, Verdejo-Garcia A, Wiers RW, Yücel M, Thompson PM, Conrod P, Garavan H. PMID: 31746534; PMCID: PMC7237314.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    44. Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users. J Addict Dis. 2018 Jul-Dec; 37(3-4):202-210. Nie L, Zhaom Z, Wen X, Luo W, Ju T, Ren A, Wu B, London ED, Li J. PMID: 31682200.
      View in: PubMed   Mentions: 4     Fields:    
    45. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis. Int J Psychiatry Clin Pract. 2020 Mar; 24(1):31-37. Yang M, Yang C, Liu T, London ED. PMID: 31609149.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. Alexithymia and Alcohol Dependence: The Roles of Negative Mood and Alcohol Craving. Subst Use Misuse. 2019; 54(14):2380-2386. Thorberg FA, Young RM, Hasking P, Lyvers M, Connor JP, London ED, Huang YL, Feeney GFX. PMID: 31429362.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways. Am J Hum Genet. 2019 08 01; 105(2):334-350. Lam M, Hill WD, Trampush JW, Yu J, Knowles E, Davies G, Stahl E, Huckins L, Liewald DC, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Hartmann AM, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. PMID: 31374203; PMCID: PMC6699140.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    48. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 2019; 45(6):563-579. Burggren AC, Shirazi A, Ginder N, London ED. PMID: 31365275; PMCID: PMC7027431.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    49. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neurosci Biobehav Rev. 2019 10; 105:288-304. Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, van Holst RJ, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW. PMID: 31319124.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    50. Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2019 May 01; 10(1):2068. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon TD, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Lill CM, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. PMID: 31043617; PMCID: PMC6494826.
      View in: PubMed   Mentions: 7     Fields:    
    51. Baseline impulsivity may moderate L-DOPA effects on value-based decision-making. Sci Rep. 2019 04 04; 9(1):5652. Petzold J, Kienast A, Lee Y, Pooseh S, London ED, Goschke T, Smolka MN. PMID: 30948756; PMCID: PMC6449394.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    52. Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. Int J Neuropsychopharmacol. 2019 04 01; 22(4):286-291. Zorick T, Okita K, Mandelkern MA, London ED, Brody AL. PMID: 30753467; PMCID: PMC6441125.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users. Int J Neuropsychopharmacol. 2019 01 01; 22(1):1-9. Tang J, O'Neill J, Alger JR, Shen Z, Johnson MC, London ED. PMID: 29788422; PMCID: PMC6313110.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use. Cannabis Cannabinoid Res. 2018; 3(1):242-251. Burggren AC, Siddarth P, Mahmood Z, London ED, Harrison TM, Merrill DA, Small GW, Bookheimer SY. PMID: 30547094; PMCID: PMC6290479.
      View in: PubMed   Mentions: 14     Fields:    
    55. Single high-dose buprenorphine for opioid craving during withdrawal. Trials. 2018 Dec 10; 19(1):675. Ahmadi J, Jahromi MS, Ghahremani D, London ED. PMID: 30526648; PMCID: PMC6288888.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. No effect of attentional bias modification training in methamphetamine users receiving residential treatment. Psychopharmacology (Berl). 2019 Feb; 236(2):709-721. Dean AC, Nurmi EL, Moeller SJ, Amir N, Rozenman M, Ghahremani DG, Johnson M, Berberyan R, Hellemann G, Zhang Z, London ED. PMID: 30415277; PMCID: PMC6415773.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology (Berl). 2018 Dec; 235(12):3525-3534. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA. PMID: 30343364; PMCID: PMC6497451.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    58. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. Am J Psychiatry. 2019 02 01; 176(2):119-128. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, Desrivieres S, Feldstein-Ewing S, Foxe JJ, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hester R, Hutchison K, Korucuoglu O, Li CR, London E, Lorenzetti V, Luijten M, Martin-Santos R, May A, Momenan R, Morales A, Paulus MP, Pearlson G, Rousseau ME, Salmeron BJ, Schluter R, Schmaal L, Schumann G, Sjoerds Z, Stein DJ, Stein EA, Sinha R, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Whittle S, Wright MJ, Yücel M, Zhang S, Yurgelun-Todd D, Hibar DP, Jahanshad N, Evans A, Thompson PM, Glahn DC, Conrod P, Garavan H, ENIGMA Addiction Working Group. PMID: 30336705; PMCID: PMC6427822.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    59. Neural basis of smoking-induced relief of craving and negative affect: Contribution of nicotine. Addict Biol. 2019 09; 24(5):1087-1095. Faulkner P, Ghahremani DG, Tyndale RF, Paterson NE, Cox C, Ginder N, Hellemann G, London ED. PMID: 30307083.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    60. Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers. Int J Neuropsychopharmacol. 2018 09 01; 21(9):800-808. Faulkner P, Ghahremani DG, Tyndale RF, Hellemann G, London ED. PMID: 29924326; PMCID: PMC6119292.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    61. Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. Schizophr Bull. 2018 08 20; 44(5):1045-1052. Zheutlin AB, Chekroud AM, Polimanti R, Gelernter J, Sabb FW, Bilder RM, Freimer N, London ED, Hultman CM, Cannon TD. PMID: 29534239; PMCID: PMC6101611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    62. Addiction and Dopamine: Sex Differences and Insights from Studies of Smoking. Curr Opin Behav Sci. 2018 Oct; 23:150-159. Petersen N, London ED. PMID: 30746429; PMCID: PMC6368096.
      View in: PubMed   Mentions: 5  
    63. Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018). Twin Res Hum Genet. 2018 10; 21(5):394-397. Lam M, Trampush JW, Yu J, Knowles E, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Glahn DC, Malhotra AK, Lencz T. PMID: 30001766.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018 07; 50(7):912-919. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, Nagel M, Awasthi S, Barr PB, Coleman JRI, Grasby KL, Hammerschlag AR, Kaminski JA, Karlsson R, Krapohl E, Lam M, Nygaard M, Reynolds CA, Trampush JW, Young H, Zabaneh D, Hägg S, Hansell NK, Karlsson IK, Linnarsson S, Montgomery GW, Muñoz-Manchado AB, Quinlan EB, Schumann G, Skene NG, Webb BT, White T, Arking DE, Avramopoulos D, Bilder RM, Bitsios P, Burdick KE, Cannon TD, Chiba-Falek O, Christoforou A, Cirulli ET, Congdon E, Corvin A, Davies G, Deary IJ, DeRosse P, Dickinson D, Djurovic S, Donohoe G, Conley ED, Eriksson JG, Espeseth T, Freimer NA, Giakoumaki S, Giegling I, Gill M, Glahn DC, Hariri AR, Hatzimanolis A, Keller MC, Knowles E, Koltai D, Konte B, Lahti J, Le Hellard S, Lencz T, Liewald DC, London E, Lundervold AJ, Malhotra AK, Melle I, Morris D, Need AC, Ollier W, Palotie A, Payton A, Pendleton N, Poldrack RA, Räikkönen K, Reinvang I, Roussos P, Rujescu D, Sabb FW, Scult MA, Smeland OB, Smyrnis N, Starr JM, Steen VM, Stefanis NC, Straub RE, Sundet K, Tiemeier H, Voineskos AN, Weinberger DR, Widen E, Yu J, Abecasis G, Andreassen OA, Breen G, Christiansen L, Debrabant B, Dick DM, Heinz A, Hjerling-Leffler J, Ikram MA, Kendler KS, Martin NG, Medland SE, Pedersen NL, Plomin R, Polderman TJC, Ripke S, van der Sluis S, Sullivan PF, Vrieze SI, Wright MJ, Posthuma D. PMID: 29942086; PMCID: PMC6411041.
      View in: PubMed   Mentions: 452     Fields:    Translation:Humans
    65. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 05 29; 9(1):2098. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon TD, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Lill CM, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. PMID: 29844566; PMCID: PMC5974083.
      View in: PubMed   Mentions: 248     Fields:    Translation:Humans
    66. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness. Neuropsychopharmacology. 2018 07; 43(8):1745-1752. Dean AC, Morales AM, Hellemann G, London ED. PMID: 29704001; PMCID: PMC6006320.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    67. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2018 03; 43(4):925. Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. PMID: 29422498; PMCID: PMC5809796.
      View in: PubMed   Mentions: 2     Fields:    
    68. Behavioral and neural markers of cigarette-craving regulation in young-adult smokers during abstinence and after smoking. Neuropsychopharmacology. 2018 06; 43(7):1616-1622. Ghahremani DG, Faulkner P, M Cox C, London ED. PMID: 29472643; PMCID: PMC5983538.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets. Cell Rep. 2017 Nov 28; 21(9):2597-2613. Lam M, Trampush JW, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. PMID: 29186694; PMCID: PMC5789458.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    70. Brain activation during emotion regulation in women with premenstrual dysphoric disorder. Psychol Med. 2018 08; 48(11):1795-1802. Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Liang L, London ED. PMID: 29145910; PMCID: PMC9196139.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    71. Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. Psychopharmacology (Berl). 2018 01; 235(1):193-202. Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, London ED. PMID: 29022071; PMCID: PMC6726112.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    72. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Front Psychiatry. 2017; 8:156. Weinstein AM, Rosca P, Fattore L, London ED. PMID: 28878698; PMCID: PMC5572353.
      View in: PubMed   Mentions: 48  
    73. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology. 2018 03; 43(4):751-760. Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED. PMID: 28664927; PMCID: PMC5809782.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    74. Neural underpinnings of maladaptive decision-making in addictions. Pharmacol Biochem Behav. 2018 01; 164:84-98. Guttman Z, Moeller SJ, London ED. PMID: 28666893; PMCID: PMC5745312.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    75. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. PMID: 28357460; PMCID: PMC5480611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    76. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2017 Jul; 42(8):1630-1639. Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. PMID: 28262740; PMCID: PMC5518907.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    77. Stages of dysfunctional decision-making in addiction. Pharmacol Biochem Behav. 2018 01; 164:99-105. Verdejo-Garcia A, Chong TT, Stout JC, Yücel M, London ED. PMID: 28216068.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    78. A neural network that links brain function, white-matter structure and risky behavior. Neuroimage. 2017 04 01; 149:15-22. Kohno M, Morales AM, Guttman Z, London ED. PMID: 28131889; PMCID: PMC5495027.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    79. Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology. 2017 Jul; 42(8):1610-1618. Faulkner P, Ghahremani DG, Tyndale RF, Cox CM, Kazanjian AS, Paterson N, Lotfipour S, Hellemann GS, Petersen N, Vigil C, London ED. PMID: 28117337; PMCID: PMC5518898.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence. Int J Neuropsychopharmacol. 2016 11; 19(11). Okita K, Mandelkern MA, London ED. PMID: 27634830; PMCID: PMC5137283.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    81. Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment. Am J Addict. 2016 09; 25(6):486-92. Weinstein AM, Freedman N, Greif J, Yemini Z, Mishani E, London E, Chisin R, Bocher M. PMID: 27467186.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Mixture models of delay discounting and smoking behavior. Am J Drug Alcohol Abuse. 2017 05; 43(3):271-280. Hofmeyr A, Monterosso J, Dean AC, Morales AM, Bilder RM, Sabb FW, London ED. PMID: 27439543.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    83. Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence. Am J Drug Alcohol Abuse. 2016 09; 42(5):500-506. Jones HW, Dean AC, Price KA, London ED. PMID: 27398730; PMCID: PMC5055455.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    84. Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence. Neuropsychopharmacology. 2016 11; 41(12):2913-2919. Okita K, Petersen N, Robertson CL, Dean AC, Mandelkern MA, London ED. PMID: 27329684; PMCID: PMC5061883.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    85. Emotion regulation in women with premenstrual dysphoric disorder. Arch Womens Ment Health. 2016 10; 19(5):891-8. Petersen N, London ED, Liang L, Ghahremani DG, Gerards R, Goldman L, Rapkin AJ. PMID: 27155663; PMCID: PMC5024711.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    86. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals. Int J Neuropsychopharmacol. 2016 05; 19(5). Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED. PMID: 26657175; PMCID: PMC4886668.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    87. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling. Adv Pharmacol. 2016; 76:67-84. London ED. PMID: 27288074.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    88. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend. 2016 Apr 01; 161:163-70. Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. PMID: 26880595; PMCID: PMC4792713.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    89. A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapy. Psychol Addict Behav. 2016 Feb; 30(1):64-72. Thorberg FA, Young RM, Sullivan KA, Lyvers M, Hurst CP, Connor JP, Tyssen R, London ED, Noble EP, Feeney GF. PMID: 26795394.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    90. Alexithymia in relation to alcohol expectancies in alcohol-dependent outpatients. Psychiatry Res. 2016 Feb 28; 236:186-188. Thorberg FA, Young RM, Lyvers M, Sullivan KA, Hasking P, London ED, Tyssen R, Connor JP, Feeney GFX. PMID: 26775551.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. PLoS One. 2015; 10(12):e0143510. Ballard ME, Dean AC, Mandelkern MA, London ED. PMID: 26657223; PMCID: PMC4699455.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity. Neurosci Biobehav Rev. 2016 Feb; 61:35-52. Moeller SJ, London ED, Northoff G. PMID: 26657968; PMCID: PMC4731270.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    93. Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response. Neuroimage Clin. 2016; 10:107-14. Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong JY, Colloca L, Tillisch K, Mandelkern MA, Mayer EA, London ED. PMID: 26759785; PMCID: PMC4683423.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    94. Genetic imaging consortium for addiction medicine: From neuroimaging to genes. Prog Brain Res. 2016; 224:203-23. Mackey S, Kan KJ, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S, Feldstein Ewing SW, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hutchison K, Li CS, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Morales AM, Paulus MP, Paus T, Pearlson G, Schluter R, Momenan R, Schmaal L, Schumann G, Sinha R, Sjoerds Z, Stein DJ, Stein EA, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Walter H, Wright MJ, Yucel M, Yurgelun-Todd D, Hibar DP, Jahanshad N, Thompson PM, Glahn DC, Garavan H, Conrod P. PMID: 26822360; PMCID: PMC4820288.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    95. Consequences of Adolescent Smoking: Cognitive Performance, Brain Function, and Policy Implications. Biol Psychiatry. 2015 Nov 01; 78(9):596-7. London ED. PMID: 26434629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment. Neuropsychopharmacology. 2016 May; 41(6):1629-36. Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED. PMID: 26503310; PMCID: PMC4832026.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    97. Memory systems in schizophrenia: Modularity is preserved but deficits are generalized. Schizophr Res. 2015 Oct; 168(1-2):223-30. Haut KM, Karlsgodt KH, Bilder RM, Congdon E, Freimer NB, London ED, Sabb FW, Ventura J, Cannon TD. PMID: 26299707; PMCID: PMC4591239.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology. 2016 Feb; 41(3):695-703. Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED. PMID: 26119471; PMCID: PMC4707816.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    99. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J Neurosci. 2015 Apr 15; 35(15):5990-7. Robertson CL, Ishibashi K, Mandelkern MA, Brown AK, Ghahremani DG, Sabb F, Bilder R, Cannon T, Borg J, London ED. PMID: 25878272; PMCID: PMC4397600.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    100. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep; 40(10):2347-56. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. PMID: 25801501; PMCID: PMC4538349.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    101. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain. Drug Alcohol Depend. 2015 Jun 01; 151:84-91. Dean AC, Kohno M, Morales AM, Ghahremani DG, London ED. PMID: 25840750; PMCID: PMC4447566.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    102. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. Int J Neuropsychopharmacol. 2015 Jan 20; 18(7):pyu119. Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. PMID: 25603861; PMCID: PMC4540098.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    103. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res. 2015 Dec 02; 1628(Pt A):174-85. London ED, Kohno M, Morales AM, Ballard ME. PMID: 25451127; PMCID: PMC4418947.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimals
    104. Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse. Int J Neuropsychopharmacol. 2014 Oct 31; 18(3). O'Neill J, Tobias MC, Hudkins M, London ED. PMID: 25522400; PMCID: PMC4360253.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    105. In the blink of an eye: relating positive-feedback sensitivity to striatal dopamine D2-like receptors through blink rate. J Neurosci. 2014 Oct 22; 34(43):14443-54. Groman SM, James AS, Seu E, Tran S, Clark TA, Harpster SN, Crawford M, Burtner JL, Feiler K, Roth RH, Elsworth JD, London ED, Jentsch JD. PMID: 25339755; PMCID: PMC4205561.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    106. Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study. Brain Behav. 2014; 4(6):867-76. Dean AC, Kohno M, Hellemann G, London ED. PMID: 25365801; PMCID: PMC4178299.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    107. The Cerebellum and Premenstrual Dysphoric Disorder. AIMS Neurosci. 2014; 1(2):120-141. Rapkin AJ, Berman SM, London ED. PMID: 28275721; PMCID: PMC5338637.
      View in: PubMed   Mentions: 2  
    108. Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry. 2014 Jul 01; 71(7):812-20. Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED. PMID: 24850532; PMCID: PMC4119006.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    109. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):35-44. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. PMID: 24949564; PMCID: PMC4365972.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    110. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug Alcohol Depend. 2014 Aug 01; 141:21-6. Courtney KE, Ghahremani DG, London ED, Ray LA. PMID: 24880692; PMCID: PMC4166553.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    111. Large-scale brain network coupling as a potential neural metric for nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry. 2014 May; 71(5):491-2. London ED, Ghahremani DG. PMID: 24622823.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. PMID: 24733235; PMCID: PMC4161630.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    113. Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers. Neuropsychopharmacology. 2014 Jul; 39(8):1816-22. Morales AM, Ghahremani D, Kohno M, Hellemann GS, London ED. PMID: 24584328; PMCID: PMC4059909.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    114. Thalamic glutamate decreases with cigarette smoking. Psychopharmacology (Berl). 2014 Jul; 231(13):2717-24. O'Neill J, Tobias MC, Hudkins M, Oh EY, Hellemann GS, Nurmi EL, London ED. PMID: 24535652; PMCID: PMC4182312.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    115. Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder: preliminary findings on the effects of medication and symptom severity. Psychiatry Res. 2014 Apr 30; 222(1-2):17-28. Congdon E, Altshuler LL, Mumford JA, Karlsgodt KH, Sabb FW, Ventura J, McGough JJ, London ED, Cannon TD, Bilder RM, Poldrack RA. PMID: 24581734; PMCID: PMC4009011.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    116. Predicting risky choices from brain activity patterns. Proc Natl Acad Sci U S A. 2014 Feb 18; 111(7):2470-5. Helfinstein SM, Schonberg T, Congdon E, Karlsgodt KH, Mumford JA, Sabb FW, Cannon TD, London ED, Bilder RM, Poldrack RA. PMID: 24550270; PMCID: PMC3932884.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    117. Methylphenidate and brain activity in a reward/conflict paradigm: role of the insula in task performance. Eur Neuropsychopharmacol. 2014 Jun; 24(6):897-906. Ivanov I, Liu X, Clerkin S, Schulz K, Fan J, Friston K, London ED, Schwartz J, Newcorn JH. PMID: 24491951.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory control. J Cogn Neurosci. 2014 Aug; 26(8):1601-14. White CN, Congdon E, Mumford JA, Karlsgodt KH, Sabb FW, Freimer NB, London ED, Cannon TD, Bilder RM, Poldrack RA. PMID: 24405185; PMCID: PMC4119005.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    119. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. Am J Drug Alcohol Abuse. 2014 Jan; 40(1):1-9. Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED. PMID: 24359505.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    120. Exercise for methamphetamine dependence: rationale, design, and methodology. Contemp Clin Trials. 2014 Jan; 37(1):139-47. Mooney LJ, Cooper C, London ED, Chudzynski J, Dolezal B, Dickerson D, Brecht ML, Peñate J, Rawson RA. PMID: 24291456; PMCID: PMC4431553.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    121. The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region. Mol Imaging. 2013 Nov-Dec; 12(8). Ishibashi K, Robertson CL, Mandelkern MA, Morgan AT, London ED. PMID: 24447617; PMCID: PMC4103900.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. Differences in neural activation as a function of risk-taking task parameters. Front Neurosci. 2013; 7:173. Congdon E, Bato AA, Schonberg T, Mumford JA, Karlsgodt KH, Sabb FW, London ED, Cannon TD, Bilder RM, Poldrack RA. PMID: 24137106; PMCID: PMC3786224.
      View in: PubMed   Mentions: 19  
    123. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex. 2015 Jan; 25(1):236-45. Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED. PMID: 23966584; PMCID: PMC4259280.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    124. Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Subst Use Misuse. 2013 Dec; 48(14):1553-62. Swanson AN, Shoptaw S, Heinzerling KG, Wade AC, Worley M, McCracken J, Wilson SA, Asarnow J, London ED. PMID: 23822739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology (Berl). 2013 Oct; 229(3):527-38. Groman SM, Morales AM, Lee B, London ED, Jentsch JD. PMID: 23748383; PMCID: PMC3770792.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    126. Women are more sensitive than men to prior trial events on the Stop-signal task. Br J Psychol. 2014 May; 105(2):254-72. Thakkar KN, Congdon E, Poldrack RA, Sabb FW, London ED, Cannon TD, Bilder RM. PMID: 24754812; PMCID: PMC4000536.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    127. Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers. Psychopharmacology (Berl). 2013 Sep; 229(2):345-55. Galván A, Schonberg T, Mumford J, Kohno M, Poldrack RA, London ED. PMID: 23644912; PMCID: PMC3758460.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    128. Effects of the Youth Empowerment Seminar on impulsive behavior in adolescents. J Adolesc Health. 2013 Jul; 53(1):139-41. Ghahremani DG, Oh EY, Dean AC, Mouzakis K, Wilson KD, London ED. PMID: 23601502.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    129. The Barratt Impulsiveness Scale-11: reassessment of its structure in a community sample. Psychol Assess. 2013 Jun; 25(2):631-42. Reise SP, Moore TM, Sabb FW, Brown AK, London ED. PMID: 23544402; PMCID: PMC3805371.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    130. Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain. Pain. 2013 Jul; 154(7):987-96. Jarcho JM, Feier NA, Bert A, Labus JA, Lee M, Stains J, Ebrat B, Groman SM, Tillisch K, Brody AL, London ED, Mandelkern MA, Mayer EA. PMID: 23582152; PMCID: PMC4294187.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    131. Effects of leptin deficiency and replacement on cerebellar response to food-related cues. Cerebellum. 2013 Feb; 12(1):59-67. Berman SM, Paz-Filho G, Wong ML, Kohno M, Licinio J, London ED. PMID: 22576622; PMCID: PMC3569483.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    132. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology. 2013 Jan; 38(2):259-74. Dean AC, Groman SM, Morales AM, London ED. PMID: 22948978; PMCID: PMC3527116.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimals
    133. Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder. J Affect Disord. 2013 Apr 05; 146(2):266-71. Berman SM, London ED, Morgan M, Rapkin AJ. PMID: 22868063; PMCID: PMC3529750.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    134. Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci. 2012 May 23; 32(21):7316-24. Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, Monterosso JR, Aron AR, Mandelkern MA, Poldrack RA, London ED. PMID: 22623677; PMCID: PMC3517177.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    135. Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci. 2012 Apr 25; 32(17):5843-52. Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD. PMID: 22539846; PMCID: PMC3353813.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    136. Overlapping neural substrates between intentional and incidental down-regulation of negative emotions. Emotion. 2012 Apr; 12(2):229-35. Payer DE, Baicy K, Lieberman MD, London ED. PMID: 22468617; PMCID: PMC4111128.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    137. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend. 2012 Oct 01; 125(3):230-8. Morales AM, Lee B, Hellemann G, O'Neill J, London ED. PMID: 22445480; PMCID: PMC3427723.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    138. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012 Apr; 153(4):744-754. Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. PMID: 22386471; PMCID: PMC3816524.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    139. Parental substance abuse and function of the motivation and behavioral inhibition systems in drug-naïve youth. Psychiatry Res. 2012 Feb 28; 201(2):128-35. Ivanov I, Liu X, Shulz K, Fan J, London E, Friston K, Halperin JM, Newcorn JH. PMID: 22386967; PMCID: PMC3335432.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    140. Acute cigarette smoking reduces latencies on a Smoking Stroop test. Addict Behav. 2012 May; 37(5):627-31. Canamar CP, London E. PMID: 22325952; PMCID: PMC3425374.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    141. Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol. 2012 Aug; 15(7):989-94. Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B, Moallem N, London ED. PMID: 22243762; PMCID: PMC4113216.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    142. Cigarette smoking and white matter microstructure. Psychopharmacology (Berl). 2012 May; 221(2):285-95. Hudkins M, O'Neill J, Tobias MC, Bartzokis G, London ED. PMID: 22215225; PMCID: PMC4111107.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    143. Educational attainment is not a good proxy for cognitive function in methamphetamine dependence. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):249-54. Dean AC, Hellemann G, Sugar CA, London ED. PMID: 22206606; PMCID: PMC4111102.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    144. Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs. 2011 Nov; 72(6):943-53. Dean AC, Sevak RJ, Monterosso JR, Hellemann G, Sugar CA, London ED. PMID: 22051208; PMCID: PMC3211965.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    145. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res. 2011 Dec 30; 194(3):287-295. Nestor LJ, Ghahremani DG, Monterosso J, London ED. PMID: 22047731; PMCID: PMC3225642.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    146. Short-term plasticity of gray matter associated with leptin deficiency and replacement. J Clin Endocrinol Metab. 2011 Aug; 96(8):E1212-20. London ED, Berman SM, Chakrapani S, Delibasi T, Monterosso J, Erol HK, Paz-Filho G, Wong ML, Licinio J. PMID: 21613360; PMCID: PMC3146795.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    147. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci. 2011 May 18; 31(20):7291-9. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD. PMID: 21593313; PMCID: PMC3114883.
      View in: PubMed   Mentions: 61     Fields:    Translation:Animals
    148. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):500-3. Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED. PMID: 21592681; PMCID: PMC3181284.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    149. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry. 2011 Sep; 68(9):953-60. Brody AL, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR, Vellios EE, Archie MM, Bascom R, Mukhin AG. PMID: 21536968; PMCID: PMC3380615.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    150. Different forms of self-control share a neurocognitive substrate. J Neurosci. 2011 Mar 30; 31(13):4805-10. Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakrapani S, Lee B, London ED. PMID: 21451018; PMCID: PMC3096483.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    151. Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test. Psychopharmacology (Berl). 2011 Jun; 215(4):801-11. Dean AC, Sugar CA, Hellemann G, London ED. PMID: 21293849; PMCID: PMC3102183.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    152. Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology. 2011 Apr; 36(5):950-9. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED. PMID: 21289606; PMCID: PMC3077264.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    153. Neural correlates of response inhibition and cigarette smoking in late adolescence. Neuropsychopharmacology. 2011 Apr; 36(5):970-8. Galván A, Poldrack RA, Baker CM, McGlennen KM, London ED. PMID: 21270772; PMCID: PMC3077266.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    154. Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry. 2011 May; 68(5):505-15. Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL. PMID: 21199957; PMCID: PMC3214639.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    155. Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. Am J Drug Alcohol Abuse. 2011 Jan; 37(1):62-7. Zorick T, Mandelkern MA, Lee B, Wong ML, Miotto K, Shabazian J, London ED. PMID: 21142706; PMCID: PMC3056536.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    156. Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry. 2011 Feb 15; 69(4):374-80. Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED. PMID: 21092938; PMCID: PMC3053132.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    157. Neural correlates of affect processing and aggression in methamphetamine dependence. Arch Gen Psychiatry. 2011 Mar; 68(3):271-82. Payer DE, Lieberman MD, London ED. PMID: 21041607; PMCID: PMC3447632.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    158. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010 Oct; 105(10):1809-18. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED. PMID: 20840201; PMCID: PMC3071736.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansPHPublic Health
    159. Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. Psychiatry Res. 2010 Sep 30; 183(3):218-24. Brody AL, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA. PMID: 20682457; PMCID: PMC2947623.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    160. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody AL, Newton TF. PMID: 20643158; PMCID: PMC2951480.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    161. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs. 2010 May; 71(3):335-44. Simon SL, Dean AC, Cordova X, Monterosso JR, London ED. PMID: 20409426; PMCID: PMC2859784.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    162. Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine. Psychiatry Res. 2010 Jan 30; 181(1):71-6. Bauer M, Berman SM, Schlagenhauf F, Voytek B, Rasgon N, Mandelkern MA, Whybrow PC, London ED. PMID: 19962861.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    163. White-matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacology (Berl). 2010 Mar; 209(1):13-24. Tobias MC, O'Neill J, Hudkins M, Bartzokis G, Dean AC, London ED. PMID: 20101394; PMCID: PMC2819660.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    164. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol. 2010; 2:13-8. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. PMID: 27186086; PMCID: PMC2915574.
      View in: PubMed   Mentions: 12  
    165. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009 Nov 25; 29(47):14734-40. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. PMID: 19940168; PMCID: PMC2822639.
      View in: PubMed   Mentions: 207     Fields:    Translation:HumansCells
    166. Effect of the TaqIA polymorphism on ethanol response in the brain. Psychiatry Res. 2009 Dec 30; 174(3):163-70. London ED, Berman SM, Mohammadian P, Ritchie T, Mandelkern MA, Susselman MK, Schlagenhauf F, Noble EP. PMID: 19914044; PMCID: PMC2796116.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    167. Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology. 2010 Feb; 35(3):775-82. Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody AL, London ED. PMID: 19907418; PMCID: PMC2813980.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    168. Effects of treatment for tobacco dependence on resting cerebral glucose metabolism. Neuropsychopharmacology. 2010 Feb; 35(3):605-12. Costello MR, Mandelkern MA, Shoptaw S, Shulenberger S, Baker SK, Abrams AL, Xia C, London ED, Brody AL. PMID: 19865076; PMCID: PMC2813904.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    169. Decision-making and facial emotion recognition as predictors of substance-use initiation among adolescents. Addict Behav. 2010 Mar; 35(3):286-9. Ernst M, Luckenbaugh DA, Moolchan ET, Temple VA, Jenness J, Korelitz KE, London ED, Kimes AS. PMID: 19914005.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    170. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):173-80. De La Garza R, Zorick T, London ED, Newton TF. PMID: 19781865; PMCID: PMC2815156.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    171. Laterality of cortical response to ethanol is moderated by TaqIA A1 allele. Synapse. 2009 Sep; 63(9):817-21. Berman SM, Noble EP, Mohammadian P, Ritchie T, Mandelkern MA, London ED. PMID: 19504620; PMCID: PMC2749503.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):186-93. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. PMID: 19698734; PMCID: PMC2775447.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    173. Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology. 2009 Dec; 34(13):2721-32. Rao U, Hammen CL, London ED, Poland RE. PMID: 19693006; PMCID: PMC2784160.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    174. Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry. 2009 Nov 01; 66(9):898-901. Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. PMID: 19640507; PMCID: PMC2763050.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    175. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):48-55. Dean AC, London ED, Sugar CA, Kitchen CM, Swanson AN, Heinzerling KG, Kalechstein AD, Shoptaw S. PMID: 19608354; PMCID: PMC2754143.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    176. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend. 2009 Oct 01; 104(3):228-40. Prosser J, London ED, Galynker II. PMID: 19608356.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    177. Studying addiction in the age of neuroimaging. Marian W. Fischman Lecture given at the 2008 meeting of CPDD. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):182-5. London ED. PMID: 19160567.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    178. Magnetic resonance imaging studies of cigarette smoking. Handb Exp Pharmacol. 2009; (192):113-43. Azizian A, Monterosso J, O'Neill J, London ED. PMID: 19184648.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    179. Handbook of experimental pharmacology 192. Nicotine psychopharmacology. Preface. Handb Exp Pharmacol. 2009; (192):v-viii. Henningfield JE, London ED, Pogun S. PMID: 19301485.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    180. Character pathology and neuropsychological test performance in remitted opiate dependence. Subst Abuse Treat Prev Policy. 2008 Nov 19; 3:23. Prosser JM, Eisenberg D, Davey EE, Steinfeld M, Cohen LJ, London ED, Galynker II. PMID: 19019247; PMCID: PMC2633291.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    181. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res. 2008 Nov; 10(11):1653-61. Xu J, Azizian A, Monterosso J, Domier CP, Brody AL, Fong TW, London ED. PMID: 18988078; PMCID: PMC2774521.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    182. Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci. 2008 Oct; 1141:195-220. Berman S, O'Neill J, Fears S, Bartzokis G, London ED. PMID: 18991959; PMCID: PMC2769923.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansAnimalsCells
    183. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol. 2009 Apr; 12(3):305-16. Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG. PMID: 18706128; PMCID: PMC2773668.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    184. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology. 2009 Jan; 34(2):282-9. Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED. PMID: 18563061; PMCID: PMC2777990.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    185. Severity of nicotine dependence moderates performance on perceptual-motor tests of attention. Nicotine Tob Res. 2008 Apr; 10(4):599-606. Azizian A, Monterosso JR, Brody AL, Simon SL, London ED. PMID: 18418782; PMCID: PMC2773663.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    186. Inhibitory control deficits in childhood and risk for substance use disorders: a review. Am J Drug Alcohol Abuse. 2008; 34(3):239-58. Ivanov I, Schulz KP, London ED, Newcorn JH. PMID: 18428067.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    187. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18276-9. Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J. PMID: 17986612; PMCID: PMC2084333.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    188. Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):93-102. Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED. PMID: 17964741; PMCID: PMC2270785.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    189. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007 Nov; 92(11):4107-14. Maki PM, Ernst M, London ED, Mordecai KL, Perschler P, Durso SC, Brandt J, Dobs A, Resnick SM. PMID: 17726086.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    190. Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl). 2007 Nov; 195(1):1-9. Domier CP, Monterosso JR, Brody AL, Simon SL, Mendrek A, Olmstead R, Jarvik ME, Cohen MS, London ED. PMID: 17634928; PMCID: PMC2796691.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    191. Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend. 2007 Oct 08; 90(2-3):166-74. Galynker II, Eisenberg D, Matochik JA, Gertmenian-King E, Cohen L, Kimes AS, Contoreggi C, Kurian V, Ernst M, Rosenthal RN, Prosser J, London ED. PMID: 17521829; PMCID: PMC2063442.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    192. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp. 2007 May; 28(5):383-93. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED. PMID: 16944492; PMCID: PMC6871407.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    193. Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys. Neuropsychopharmacology. 2008 Jan; 33(2):270-8. Chefer SI, Kimes AS, Matochik JA, Horti AG, Kurian V, Shumway D, Domino EF, London ED, Mukhin AG. PMID: 17429408.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    194. Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction. 2007 Apr; 102 Suppl 1:5-15. Baicy K, London ED. PMID: 17493049.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    195. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology. 2007 Oct; 32(10):2125-34. Lee B, Groman S, London ED, Jentsch JD. PMID: 17299511.
      View in: PubMed   Mentions: 81     Fields:    Translation:Animals
    196. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry. 2007 Sep 15; 62(6):642-51. Brody AL, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS. PMID: 17217932; PMCID: PMC1992815.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    197. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology. 2007 Jun; 32(6):1421-8. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Jarvik M, Olmstead R, Brody AL, Ernst M, London ED. PMID: 17164821; PMCID: PMC2876092.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    198. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study. Psychiatry Res. 2006 Dec 01; 148(2-3):103-9. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Brody AL, Jarvik M, Rodriguez P, Ernst M, London ED. PMID: 17088048; PMCID: PMC1817900.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    199. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology. 2006 Dec; 31(12):2716-27. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasic JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED. PMID: 16971900.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansCells
    200. Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci. 2006 Aug 23; 26(34):8707-14. Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH. PMID: 16928859; PMCID: PMC6674379.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansAnimals
    201. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006 Aug; 63(8):907-15. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG. PMID: 16894067; PMCID: PMC2773659.
      View in: PubMed   Mentions: 181     Fields:    Translation:Humans
    202. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006 Jul; 63(7):808-16. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. PMID: 16818870; PMCID: PMC2873693.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    203. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics. 2006 Jun; 117(6):2030-9. Ernst M, Luckenbaugh DA, Moolchan ET, Leff MK, Allen R, Eshel N, London ED, Kimes A. PMID: 16740845.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    204. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend. 2006 Oct 01; 84(3):240-7. Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. PMID: 16545923; PMCID: PMC2067988.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    205. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov; 32(8):869-74. Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED. PMID: 16253812.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    206. Education-associated cortical glucose metabolism during sustained attention. Neuroreport. 2005 Sep 08; 16(13):1473-6. Eisenberg DP, London ED, Matochik JA, Derbyshire S, Cohen LJ, Steinfeld M, Prosser J, Galynker II. PMID: 16110274; PMCID: PMC2254316.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    207. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005 Nov 15; 58(10):770-8. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W. PMID: 16095568.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    208. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers. Synapse. 2005 Aug; 57(2):113-5. Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, Brody AL, Monterosso J, Ling W, London ED. PMID: 15906384.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    209. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005 Jul 15; 58(2):143-50. Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, Brody A, Jarvik M, Domier CP, Olmstead R, Ernst M, London ED. PMID: 16038685; PMCID: PMC2773671.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    210. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav. 2006 May; 31(5):833-44. Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED. PMID: 16009504; PMCID: PMC2773651.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    211. Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers. Brain Res Cogn Brain Res. 2005 Apr; 23(1):119-36. Fishbein DH, Eldreth DL, Hyde C, Matochik JA, London ED, Contoreggi C, Kurian V, Kimes AS, Breeden A, Grant S. PMID: 15795139.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCTClinical Trials
    212. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005 Aug 01; 79(2):273-7. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. PMID: 15967595.
      View in: PubMed   Mentions: 175     Fields:    Translation:Humans
    213. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab. 2005 May; 90(5):2851-4. Matochik JA, London ED, Yildiz BO, Ozata M, Caglayan S, DePaoli AM, Wong ML, Licinio J. PMID: 15713712.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    214. Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers. Exp Clin Psychopharmacol. 2005 Feb; 13(1):25-40. Fishbein D, Hyde C, Eldreth D, London ED, Matochik J, Ernst M, Isenberg N, Steckley S, Schech B, Kimes A. PMID: 15727501.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    215. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors. Synapse. 2005 Feb; 55(2):89-97. Gündisch D, Koren AO, Horti AG, Pavlova OA, Kimes AS, Mukhin AG, London ED. PMID: 15529332.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    216. Common substrates of dysphoria in stimulant drug abuse and primary depression: therapeutic targets. Int Rev Neurobiol. 2005; 65:117-45. Baicy K, Bearden CE, Monterosso J, Brody AL, Isaacson AJ, London ED. PMID: 16140055.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    217. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. J Pharmacol Exp Ther. 2005 Jan; 312(1):355-65. Vaupel DB, Tella SR, Huso DL, Wagner VO, Mukhin AG, Chefer SI, Horti AG, London ED, Koren AO, Kimes AS. PMID: 15331657.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    218. Smoking-induced ventral striatum dopamine release. Am J Psychiatry. 2004 Jul; 161(7):1211-8. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA. PMID: 15229053.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    219. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004 Jun 30; 24(26):6028-36. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. PMID: 15229250; PMCID: PMC6729247.
      View in: PubMed   Mentions: 287     Fields:    Translation:HumansCells
    220. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res. 2004 Apr 30; 130(3):269-81. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED. PMID: 15135160; PMCID: PMC2773650.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    221. Age-related decline in striatal volume in rhesus monkeys: assessment of long-term calorie restriction. Neurobiol Aging. 2004 Feb; 25(2):193-200. Matochik JA, Chefer SI, Lane MA, Roth GS, Mattison JA, London ED, Ingram DK. PMID: 14749137.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    222. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug Alcohol Depend. 2004 Jan 07; 73(1):79-86. Rotheram-Fuller E, Shoptaw S, Berman SM, London ED. PMID: 14687962.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    223. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004; 16(4):456-64. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E. PMID: 15616172; PMCID: PMC2771441.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    224. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry. 2004 Jan 01; 55(1):77-84. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED. PMID: 14706428.
      View in: PubMed   Mentions: 176     Fields:    Translation:Humans
    225. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004 Jan; 61(1):73-84. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. PMID: 14706946.
      View in: PubMed   Mentions: 169     Fields:    Translation:Humans
    226. Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging. 2003 Dec; 30(12):1620-9. Fujita M, Ichise M, van Dyck CH, Zoghbi SS, Tamagnan G, Mukhin AG, Bozkurt A, Seneca N, Tipre D, DeNucci CC, Iida H, Vaupel DB, Horti AG, Koren AO, Kimes AS, London ED, Seibyl JP, Baldwin RM, Innis RB. PMID: 14523584.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    227. Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats. Neuroreport. 2003 Aug 06; 14(11):1503-5. Liu X, Koren AO, Yee SK, Pechnick RN, Poland RE, London ED. PMID: 12960773.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    228. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage. 2003 Jul; 19(3):1095-102. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI. PMID: 12880835.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansCTClinical Trials
    229. Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2003 Jun; 160(6):1061-70. Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, Contoreggi C, Leff M, Bolla K. PMID: 12777263.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    230. 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J. 2003 Jul; 17(10):1331-3. Kimes AS, Horti AG, London ED, Chefer SI, Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG. PMID: 12759330.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    231. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse. 2003 Apr; 48(1):25-34. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG. PMID: 12557269.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    232. PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry. 2003 Feb; 160(2):323-33. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC, Turkington TG, Coleman RE. PMID: 12562580.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    233. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry. 2003 Jan; 160(1):33-40. Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L. PMID: 12505799.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    234. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002 Dec; 59(12):1162-72. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR, Madsen D, Jarvik ME. PMID: 12470133.
      View in: PubMed   Mentions: 200     Fields:    Translation:HumansCTClinical Trials
    235. Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study. Neuropsychopharmacology. 2003 Apr; 28(4):765-72. Stapleton JM, Gilson SF, Wong DF, Villemagne VL, Dannals RF, Grayson RF, Henningfield JE, London ED. PMID: 12655323.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    236. Incorporating brain research findings into standard treatment: an example using the Matrix Model. J Subst Abuse Treat. 2002 Sep; 23(2):107-13. Obert JL, London ED, Rawson RA. PMID: 12220608.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    237. Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology. 2002 May; 26(5):682-91. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED. PMID: 11927193.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    238. Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging. 2002 Feb; 29(2):183-90. Fujita M, Seibyl JP, Vaupel DB, Tamagnan G, Early M, Zoghbi SS, Baldwin RM, Horti AG, KoreN AO, Mukhin AG, Khan S, Bozkurt A, Kimes AS, London ED, Innis RB. PMID: 11926380.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Edythe's Networks
    Concepts (524)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (57)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California